Cilofexor, a nonsteroidal FXR agonist, in patients with noncirrhotic NASH: a phase 2 randomized controlled trial by Cyrus Huneycutt | Dec 16, 2023 | 0 comments Submit a Comment Cancel replyYou must be logged in to post a comment.
Recent Comments